SLPI and breast cancer: Altered expressions of SLPI and elafin have been identified in several carcinomas, and it appears that these aberrations may play a role in tumor formation, stimulation of metastatic potential, and development of malignant behavior in cancer cells, including breast cancer (BC) (12, 13).